Single infusion of Lilly gene editing cuts cholesterol with the company planning long-term study

May 27, 2026 Latest News BioPharma

This is a preview of subscriber content

Subscribe now to continue reading.

A single intravenous infusion of Lilly's investigational base editor VERVE‑102 produced dose-dependent reductions in PCSK9 of up to 88 per cent and LDL cholesterol of up to 62 per cent, with effects sustained for up to 18 months. …

Subscribe now to continue reading.

Latest Video

Officials talk down the prospect of MFN impact on the PBS
June 4, 2026 - Latest News
An exchange that reveals the truth of a review that has now become a lot like 'Weekend at Bernie's'
June 3, 2026 - Latest News
A clear disconnect between the public and private on 'Most Favored Nation' pricing
June 5, 2026 - Latest News
Officials cite company consultation, system changes, and spending approvals to justify delay
June 4, 2026 - Latest News
Novo Nordisk's Marie Krogh Prize returns and crosses the Tasman to back early career women in science
June 4, 2026 - Latest News

Single infusion of Lilly gene editing cuts cholesterol with the company planning long-term study

This is a preview of subscriber content

Latest Video

Most Read

Officials talk down the prospect of MFN impact on the PBS

An exchange that reveals the truth of a review that has now become a lot like 'Weekend at Bernie's'

A clear disconnect between the public and private on 'Most Favored Nation' pricing

Officials cite company consultation, system changes, and spending approvals to justify delay

Novo Nordisk's Marie Krogh Prize returns and crosses the Tasman to back early career women in science

New Stories

The 'Dispatched' Podcast - Special episode

Opthea returns to ASX and works to restart eye therapy candidate

A clear disconnect between the public and private on 'Most Favored Nation' pricing

New blueprint charts a potential policy path forward on biosimilars

Study confirms pharmacist led care expands timely access to urinary tract infection treatment and contraception

Officials talk down the prospect of MFN impact on the PBS

Novo Nordisk's Marie Krogh Prize returns and crosses the Tasman to back early career women in science

Sign In

Single infusion of Lilly gene editing cuts cholesterol with the company planning long-term study

This is a preview of subscriber content

Latest Video

Most Read

Officials talk down the prospect of MFN impact on the PBS

An exchange that reveals the truth of a review that has now become a lot like 'Weekend at Bernie's'

A clear disconnect between the public and private on 'Most Favored Nation' pricing

Officials cite company consultation, system changes, and spending approvals to justify delay

Novo Nordisk's Marie Krogh Prize returns and crosses the Tasman to back early career women in science

Follow Us

New Stories

The 'Dispatched' Podcast - Special episode

Opthea returns to ASX and works to restart eye therapy candidate

A clear disconnect between the public and private on 'Most Favored Nation' pricing

New blueprint charts a potential policy path forward on biosimilars

Study confirms pharmacist led care expands timely access to urinary tract infection treatment and contraception

Officials talk down the prospect of MFN impact on the PBS

Novo Nordisk's Marie Krogh Prize returns and crosses the Tasman to back early career women in science